
NASDAQ:NBIX
Neurocrine Biosciences is a American stock, trading under the symbol NBIX (previously NBIX-Q on Stockchase) on the NASDAQ (NBIX). It is usually referred to as NASDAQ:NBIX or NBIX
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on NBIX (previously NBIX-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is PARTIAL BUY. Read the latest stock experts' ratings for Neurocrine Biosciences.
Neurocrine Biosciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Neurocrine Biosciences.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Neurocrine Biosciences.
Neurocrine Biosciences is covered by Stockchase experts and is worth watching.
On 2026-08-17, Neurocrine Biosciences (NBIX) stock closed at a price of $154.49.
They're profitable though neurological issues are very tough, an area that most doctors won't touch.